Congratulations to Dr. Terrance Snutch, who has been awarded the 13th annual Margolese National Brain Disorders Prize for his combination of ground-breaking research, drug design and development, and clinical and commercial translation – all directly contributing to treatments for brain disorders.
Dr. Snutch is a professor in UBC’s Department of Psychiatry, a member of the Djavad Mowafaghian Centre for Brain Health and a founding member of the Michael Smith Laboratories.
As a world-renowned expert in neurobiology, he is in part recognized for his ground-breaking research in the identification and characterization of the voltage-gated calcium channel family underlying signaling responsible for neurophysiological properties. He is further acknowledged for his exceptional contributions in translational research and drug development related to brain disorders, including de novo drug design.
Dr. Snutch’s unique and vast portfolio laid the foundation for broad aspects of calcium channel research today and contributed to unravelling fundamental mechanisms in neurobiology.
One of Canada’s most prolific and visionary innovators, Dr. Snutch has contributed greatly to the design of first-in-class drugs aimed at treating brain disorders, the identification of numerous new molecular targets underlying brain diseases, screening methodologies and improved drug oral formulations, as reflected in over 100 U.S. and international issued patents.
The Margolese prizes were created by an estate gift to UBC by Leonard Herbert Margolese to recognize Canadians who have made outstanding contributions to the treatment, amelioration or cure of brain or heart disorders. Margolese, who passed away in 2000, was a Vancouver businessman who had a heart condition and whose brother had Alzheimer’s disease.